Mario León

Learn More
Objective To assess the effectiveness and functional capacity with rheumatoid artritis treated with biologic after dose reduction. Methods A retrospective study on a cohort of 13 patients diagnosed rheumatoid artritis treated with anti-TNF (10 patients with etanercept, and 3 with adalimumab) and clinical remission (DAS28 < 2.6) in the last 6 mounths, in(More)
Objective To assess the clinical and economic efficiency as well as functional capacity in patients with rheumatoid artritis treated with biologic after dose reduction. Methods A retrospective study on a cohort of 13 patients diagnosed rheumatoid artritis (RA) treated with anti-TNF (10 patients with etanercept, and 3 with adalimumab) and clinical remission(More)
Objective To evaluate the clinical and functional activity of patients with rheumatoid arthritis at one and two years after starting anti-TNF therapy. This is a retrospective study of 50 RA patients, who started ANTI-TNF theraphy between June 2006 and july 2009. The main variables in the study were: DAS28, HAQ and pain VAS. We analyzed evolution after 1(More)
  • 1